EXANE DERIVATIVES - LEAP THERAPEUTICS INC ownership

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$20,968,000
-23.7%
14,4610.0%0.01%
-37.5%
Q1 2021$27,475,000
-15.6%
14,4610.0%0.01%
-20.0%
Q4 2020$32,536,00014,4610.01%
Other shareholders

There were no reported owners of LEAP THERAPEUTICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of LEAP THERAPEUTICS INC shareholders